Treatment of Hyponatremia in SIADH

Diagnosis and Treatment Guidelines

• The American Thoracic Society recommends fluid restriction to 1 L/day as the first-line treatment for asymptomatic or mild SIADH-induced hyponatremia, while hypertonic 3% saline is reserved for severe symptomatic cases with careful monitoring to prevent osmotic demyelination syndrome 1, 2, 3
• SIADH is characterized by hyponatremia (serum sodium < 134 mEq/L), hypoosmolality (plasma osmolality < 275 mosm/kg), inappropriately high urine osmolality (> 500 mosm/kg), and inappropriately high urinary sodium concentration (> 20 mEq/L) in the absence of hypothyroidism, adrenal insufficiency, or volume depletion 1
• For severe symptomatic hyponatremia, administer 3% hypertonic saline with a goal to correct 6 mmol/L over 6 hours or until severe symptoms resolve, with total correction not exceeding 8 mmol/L in 24 hours to prevent osmotic demyelination syndrome 2, 3, 4
• The American Association of Neurological Surgeons recommends monitoring serum sodium every 2 hours initially and transferring to ICU for close monitoring in severe cases 2
• For mild symptomatic hyponatremia or asymptomatic hyponatremia with sodium < 120 mEq/L, fluid restriction to 1 L/day is recommended, with monitoring of sodium every 4 hours 1, 2, 3
• Demeclocycline is considered an alternative option for second-line treatment of hyponatremia in SIADH 1
• The correction rate for severe hyponatremia should be limited to < 8 mmol/L per 24 hours, and for chronic hyponatremia, slower correction is safer to prevent osmotic demyelination syndrome 2, 3, 4
• Patients with malnutrition, alcoholism, or advanced liver disease require more cautious correction rates (4-6 mmol/L per day) 4
• Failing to recognize and treat the underlying cause of SIADH is a common pitfall to avoid 4

Treatment of Hyponatremia Secondary to SIADH

Initial Treatment

• The American Academy of Neurosurgery recommends implementing fluid restriction to 1 L/day as first-line therapy for mild symptomatic or asymptomatic hyponatremia, with a correction rate averaging 1.0 mEq/L/day with fluid restriction alone 5

Second-Line Pharmacological Options

• Urea (0.25-0.50 g/kg/day) is highly effective for chronic SIADH management, inducing osmotic water drive, and is well-tolerated long-term, though distaste is common (54% of patients) 5
• Demeclocycline induces nephrogenic diabetes insipidus, reducing the kidney's response to ADH, and is considered second-line when fluid restriction is ineffective 5

Critical Correction Rate Guidelines

• The guideline recommends never exceeding 8 mmol/L correction in 24 hours for chronic hyponatremia, with high-risk patients requiring even slower correction (4-6 mmol/L per day) 5

Special Considerations

• The Neurosurgery society warns against using fluid restriction in subarachnoid hemorrhage patients at risk for vasospasm, as this worsens outcomes, and recommends considering fludrocortisone or hydrocortisone instead in these neurosurgical patients 5
• It is essential to distinguish SIADH from cerebral salt wasting (CSW), as they require opposite treatments, with SIADH being euvolemic and treated with fluid restriction, and CSW being hypovolemic and treated with volume and sodium replacement 5